| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.53e-04 | 16 | 35 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.42e-04 | 85 | 35 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.14e-04 | 21 | 35 | 2 | GO:0030228 | |
| GeneOntologyCellularComponent | sarcomere | 6.88e-04 | 249 | 34 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 9.69e-04 | 273 | 34 | 4 | GO:0030016 | |
| GeneOntologyCellularComponent | M band | 1.16e-03 | 31 | 34 | 2 | GO:0031430 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.21e-03 | 290 | 34 | 4 | GO:0043292 | |
| Domain | EGF_3 | 4.45e-06 | 235 | 35 | 6 | PS50026 | |
| Domain | EGF | 4.45e-06 | 235 | 35 | 6 | SM00181 | |
| Domain | EGF-like_dom | 6.21e-06 | 249 | 35 | 6 | IPR000742 | |
| Domain | EGF_2 | 8.86e-06 | 265 | 35 | 6 | PS01186 | |
| Domain | - | 2.91e-05 | 95 | 35 | 4 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 4.86e-05 | 38 | 35 | 3 | PS50025 | |
| Domain | ConA-like_dom | 5.16e-05 | 219 | 35 | 5 | IPR013320 | |
| Domain | - | 5.26e-05 | 39 | 35 | 3 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 5.68e-05 | 40 | 35 | 3 | PF02210 | |
| Domain | LamG | 7.57e-05 | 44 | 35 | 3 | SM00282 | |
| Domain | 6-blade_b-propeller_TolB-like | 8.66e-05 | 46 | 35 | 3 | IPR011042 | |
| Domain | EGF | 8.79e-05 | 126 | 35 | 4 | PF00008 | |
| Domain | EGF_1 | 1.06e-04 | 255 | 35 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.18e-04 | 261 | 35 | 5 | IPR013032 | |
| Domain | Sialidases | 1.22e-04 | 9 | 35 | 2 | IPR011040 | |
| Domain | Laminin_G | 1.73e-04 | 58 | 35 | 3 | IPR001791 | |
| Domain | Ldl_recept_b | 3.06e-04 | 14 | 35 | 2 | PF00058 | |
| Domain | LDLRB | 3.06e-04 | 14 | 35 | 2 | PS51120 | |
| Domain | LY | 3.53e-04 | 15 | 35 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.53e-04 | 15 | 35 | 2 | IPR000033 | |
| Domain | EGF_CA | 5.55e-04 | 86 | 35 | 3 | PF07645 | |
| Domain | FA58C | 7.01e-04 | 21 | 35 | 2 | SM00231 | |
| Domain | FA58C_3 | 7.01e-04 | 21 | 35 | 2 | PS50022 | |
| Domain | FA58C_1 | 7.01e-04 | 21 | 35 | 2 | PS01285 | |
| Domain | FA58C_2 | 7.01e-04 | 21 | 35 | 2 | PS01286 | |
| Domain | SRCR | 7.01e-04 | 21 | 35 | 2 | PF00530 | |
| Domain | EGF_Ca-bd_CS | 7.88e-04 | 97 | 35 | 3 | IPR018097 | |
| Domain | EGF_CA | 8.36e-04 | 99 | 35 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 8.61e-04 | 100 | 35 | 3 | PS00010 | |
| Domain | F5_F8_type_C | 9.18e-04 | 24 | 35 | 2 | PF00754 | |
| Domain | FA58C | 9.18e-04 | 24 | 35 | 2 | IPR000421 | |
| Domain | SR | 9.96e-04 | 25 | 35 | 2 | SM00202 | |
| Domain | - | 9.96e-04 | 25 | 35 | 2 | 3.10.250.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.02e-03 | 106 | 35 | 3 | IPR000152 | |
| Domain | SRCR_1 | 1.08e-03 | 26 | 35 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 1.08e-03 | 26 | 35 | 2 | IPR017448 | |
| Domain | SRCR_2 | 1.08e-03 | 26 | 35 | 2 | PS50287 | |
| Domain | SRCR | 1.16e-03 | 27 | 35 | 2 | IPR001190 | |
| Domain | EGF_CA | 1.53e-03 | 122 | 35 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.60e-03 | 124 | 35 | 3 | IPR001881 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.63e-03 | 32 | 35 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.63e-03 | 32 | 35 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 1.63e-03 | 32 | 35 | 2 | PS00514 | |
| Domain | LDLR_class-A_CS | 2.54e-03 | 40 | 35 | 2 | IPR023415 | |
| Domain | Growth_fac_rcpt_ | 3.08e-03 | 156 | 35 | 3 | IPR009030 | |
| Domain | Ldl_recept_a | 3.21e-03 | 45 | 35 | 2 | PF00057 | |
| Domain | - | 3.35e-03 | 46 | 35 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.65e-03 | 48 | 35 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.80e-03 | 49 | 35 | 2 | IPR002172 | |
| Domain | LDLa | 3.80e-03 | 49 | 35 | 2 | SM00192 | |
| Domain | LDLRA_2 | 3.80e-03 | 49 | 35 | 2 | PS50068 | |
| Domain | Sushi | 4.27e-03 | 52 | 35 | 2 | PF00084 | |
| Domain | CCP | 4.59e-03 | 54 | 35 | 2 | SM00032 | |
| Domain | SUSHI | 4.93e-03 | 56 | 35 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 5.10e-03 | 57 | 35 | 2 | IPR000436 | |
| Domain | EGF_extracell | 5.64e-03 | 60 | 35 | 2 | IPR013111 | |
| Domain | EGF_2 | 5.64e-03 | 60 | 35 | 2 | PF07974 | |
| Domain | PH_dom-like | 7.99e-03 | 426 | 35 | 4 | IPR011993 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19002483 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31150793 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17720975 | ||
| Pubmed | Obscurin is a ligand for small ankyrin 1 in skeletal muscle. | 1.04e-06 | 2 | 36 | 2 | 12631729 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 26807827 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20971078 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12527750 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 20168092 | ||
| Pubmed | Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover. | 6.24e-06 | 4 | 36 | 2 | 22573887 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16962094 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 24128730 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.56e-05 | 6 | 36 | 2 | 34143959 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 24668264 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 23640897 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 15522233 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 20417604 | ||
| Pubmed | Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. | 3.73e-05 | 9 | 36 | 2 | 18083104 | |
| Pubmed | Disruption of FAT10-MAD2 binding inhibits tumor progression. | 4.66e-05 | 10 | 36 | 2 | 25422469 | |
| Pubmed | 8.54e-05 | 225 | 36 | 4 | 12168954 | ||
| Pubmed | FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. | 9.41e-05 | 14 | 36 | 2 | 25126726 | |
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 25198012 | ||
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 1.24e-04 | 16 | 36 | 2 | 16096065 | |
| Pubmed | 1.27e-04 | 1116 | 36 | 7 | 31753913 | ||
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 26389685 | ||
| Pubmed | 1.76e-04 | 19 | 36 | 2 | 36952345 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.00e-04 | 1201 | 36 | 7 | 35696571 | |
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 2.38e-04 | 22 | 36 | 2 | 26494785 | |
| Pubmed | WD40 repeat and FYVE domain containing 3 is essential for cardiac development. | 3.08e-04 | 25 | 36 | 2 | 30428088 | |
| Pubmed | 3.77e-04 | 332 | 36 | 4 | 37433992 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 4.16e-04 | 29 | 36 | 2 | 31491374 | |
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 5.07e-04 | 32 | 36 | 2 | 21546767 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 5.07e-04 | 32 | 36 | 2 | 22424883 | |
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 6.78e-04 | 37 | 36 | 2 | 24162737 | |
| Pubmed | Highly variable penetrance of abnormal phenotypes in embryonic lethal knockout mice. | 7.93e-04 | 40 | 36 | 2 | 27996060 | |
| Interaction | CST11 interactions | 2.15e-07 | 75 | 36 | 5 | int:CST11 | |
| Interaction | RLN1 interactions | 2.24e-05 | 93 | 36 | 4 | int:RLN1 | |
| Interaction | LILRA5 interactions | 2.51e-05 | 32 | 36 | 3 | int:LILRA5 | |
| Interaction | CCL26 interactions | 3.90e-05 | 37 | 36 | 3 | int:CCL26 | |
| Interaction | C2CD4B interactions | 6.59e-05 | 44 | 36 | 3 | int:C2CD4B | |
| Interaction | PATE1 interactions | 9.11e-05 | 49 | 36 | 3 | int:PATE1 | |
| Interaction | FOXD4L6 interactions | 9.11e-05 | 49 | 36 | 3 | int:FOXD4L6 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 8.51e-06 | 161 | 36 | 4 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 1.03e-05 | 169 | 36 | 4 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 1.16e-05 | 174 | 36 | 4 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 178 | 36 | 4 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.29e-05 | 179 | 36 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 182 | 36 | 4 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 36 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 36 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 36 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-05 | 186 | 36 | 4 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 186 | 36 | 4 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 187 | 36 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 188 | 36 | 4 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 188 | 36 | 4 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 188 | 36 | 4 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 189 | 36 | 4 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 189 | 36 | 4 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 192 | 36 | 4 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.81e-05 | 195 | 36 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.81e-05 | 195 | 36 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 199 | 36 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 199 | 36 | 4 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 199 | 36 | 4 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 147 | 36 | 3 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-04 | 148 | 36 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.49e-04 | 152 | 36 | 3 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-04 | 155 | 36 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.68e-04 | 156 | 36 | 3 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 157 | 36 | 3 | e96241db2b5ff52b230e3e33207e7bb968900cab | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 157 | 36 | 3 | 07a0f8d29a3111be670eae030a91474465eba734 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.22e-04 | 166 | 36 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 173 | 36 | 3 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 3.63e-04 | 173 | 36 | 3 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-04 | 175 | 36 | 3 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-04 | 175 | 36 | 3 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.82e-04 | 176 | 36 | 3 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.82e-04 | 176 | 36 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.82e-04 | 176 | 36 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 176 | 36 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.82e-04 | 176 | 36 | 3 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.82e-04 | 176 | 36 | 3 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.82e-04 | 176 | 36 | 3 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | 4d67e24653caa318039870114849426ff2582e0c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | c20df760b25caa772278397b02fc36521927cbfc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-04 | 178 | 36 | 3 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-04 | 178 | 36 | 3 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-04 | 180 | 36 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-04 | 180 | 36 | 3 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 182 | 36 | 3 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 182 | 36 | 3 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.21e-04 | 182 | 36 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 183 | 36 | 3 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-04 | 184 | 36 | 3 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-04 | 185 | 36 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.42e-04 | 185 | 36 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.42e-04 | 185 | 36 | 3 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.42e-04 | 185 | 36 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.49e-04 | 186 | 36 | 3 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 4.49e-04 | 186 | 36 | 3 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 186 | 36 | 3 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 186 | 36 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 187 | 36 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.56e-04 | 187 | 36 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.56e-04 | 187 | 36 | 3 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-04 | 188 | 36 | 3 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.63e-04 | 188 | 36 | 3 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-04 | 188 | 36 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.63e-04 | 188 | 36 | 3 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-04 | 189 | 36 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-04 | 189 | 36 | 3 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 189 | 36 | 3 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-04 | 189 | 36 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 189 | 36 | 3 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.28e-07 | 198 | 36 | 6 | 2123_DN | |
| Drug | 1,2,4-benzenetriol | 6.23e-06 | 76 | 36 | 4 | CID000010787 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.59e-05 | 8 | 34 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | energy expenditure measurement | 2.42e-04 | 20 | 34 | 2 | EFO_0008005 | |
| Disease | triacylglycerol 52:6 measurement | 3.80e-04 | 25 | 34 | 2 | EFO_0010418 | |
| Disease | white matter volume measurement | 6.25e-04 | 32 | 34 | 2 | EFO_0008320 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.13e-04 | 152 | 34 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | left ventricular systolic function measurement | 1.18e-03 | 44 | 34 | 2 | EFO_0008206 | |
| Disease | blood urea nitrogen measurement | 1.75e-03 | 452 | 34 | 4 | EFO_0004741 | |
| Disease | small cell lung carcinoma | 3.85e-03 | 80 | 34 | 2 | EFO_0000702 | |
| Disease | obsolete_red blood cell distribution width | 4.01e-03 | 1347 | 34 | 6 | EFO_0005192 | |
| Disease | carotid plaque build | 4.23e-03 | 84 | 34 | 2 | EFO_0006501 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEHGGECSQSWDTFS | 556 | Q9BZ76 | |
| RSSGKGNSSDHEGCW | 641 | Q8WY36 | |
| GSEHRTCKADGSWTG | 3226 | Q7Z408 | |
| ECSKAEDSDATGHEW | 1586 | P16157 | |
| SDWCPDGDADTHTGT | 6 | Q8N1L1 | |
| SDACDGSGDSSGDSW | 76 | Q13434 | |
| EGSECVSDPWEEKHT | 3801 | Q14517 | |
| AFGDSEGCVHLWTDS | 346 | Q504Q3 | |
| SRGWGNSDCTHDEDA | 126 | P58215 | |
| ISSKWHCDSDDDCGD | 981 | Q9NZR2 | |
| DQCSSDGWFSGTHKC | 316 | Q5T848 | |
| WECCSSSSGDADGES | 591 | Q92628 | |
| EEGWASFSCELSHED | 2571 | Q5VST9 | |
| AEEWEHCTKTCGSSG | 911 | O15072 | |
| SDSDSSCGWTVISHE | 6 | Q9ULG6 | |
| SKHWCEEGASSSSCS | 261 | Q96IY4 | |
| GFHDKDSSGWSCSKD | 51 | O15523 | |
| PWETGHCLSEGSDSS | 81 | Q9NW75 | |
| GTICDDSWDLSDAHV | 741 | Q86VB7 | |
| CEHGGECSQSWDTFS | 556 | Q96NU0 | |
| DWSDEKDCGDSHILP | 1396 | Q92673 | |
| DGVFCLLSDDHGASW | 226 | Q99519 | |
| ASGECFSWGASDSHA | 261 | Q8NDX1 | |
| GDKESSCLANSSWSH | 1881 | Q4LDE5 | |
| HGGSCNWESCFDTSK | 76 | Q92935 | |
| MESDNCSGGDDDWTH | 326 | Q13501 | |
| CSGGDDDWTHLSSKE | 331 | Q13501 | |
| EDDCFGCLSWSHSET | 146 | P13798 | |
| EGDSWICKSVLSEGH | 46 | O76071 | |
| SAADHWVKDEGGDSC | 3446 | Q8IZQ1 | |
| SGKSSVLVHCSDGWD | 366 | Q13496 | |
| DSWRSNKGCSEDHSG | 1176 | Q5JSZ5 | |
| EGATEWSDCFHIAGD | 336 | Q9BV44 | |
| DGIHSGACSDIWKVD | 71 | Q9GZX5 | |
| GAHKQCHTGTTSDWD | 486 | Q96JM2 | |
| TGPGCWHEVKDEESS | 11 | P52741 | |
| SVGCWHGAKDEEAPS | 46 | P17021 |